Success Story: From Computational Research to Recognized Impact: Physical Chemistry Expert Secures EB-1A Approval

Client’s Testimonial:

 

“Thank you so much for helping me during the case preparation process and securing the final approval.”

 


 

On August 20th, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for a Scientist in the Field of Physical Chemistry (Approval Notice).

 


 

General Field: Physical Chemistry

 

Position at the Time of Case Filing: Scientist

 

Country of Origin: China

 

Country of Residence at the Time of Filing: China

 

Approval Notice Date: August 20th, 2026

 

Processing Time: 6 months, 22 days (Premium Processing Upgrade Requested)

 


 

Case Summary:

 

Computational approaches are increasingly important for solving complex problems across areas ranging from energy technologies to biomedical research. The client holds a Ph.D. in physical chemistry and, at the time of filing, worked as a Scientist, leading and co-leading computational design programs to practical research and development challenges.

 

For the client's I-140 EB-1A petition, North America Immigration Law Group (Chen Immigration Law Associates) structured the evidence around three regulatory criteria: judging the work of others, original contributions of major significance, and authorship of scholarly articles. Beyond demonstrating that the individual criteria were satisfied, we presented the evidence collectively to establish sustained recognition and show how the client's work had influenced physical chemistry research beyond the client's own projects.

 

A central part of this strategy was showing how the client's scholarly record translated into influence. The client had authored more than 30 peer-reviewed journal articles; the published body of work had received more than 1,300 citations. Rather than relying on the citation total alone, we contextualized this record through comparative evidence. Multiple publications ranked among the most highly cited chemistry papers from their respective publication years, while independent researchers had relied on the client's findings in subsequent work involving energy storage, drug development, and computational discovery. This evidence helped demonstrate to an adjudicator that the client's research had generated measurable influence beyond publication itself.

 

The client's role in evaluating other researchers provided another perspective on professional recognition. The client had completed at least 100 peer reviews for scholarly journals. We explained that this repeated selection to assess other scientists' work reflected reliance on the client's expertise and supported the EB-1A judging criterion. Considered together with the publication and citation evidence, this record strengthened the argument that the client had developed recognized authority within the field rather than simply maintaining an active research profile.

 

We also submitted 4 recommendation letters from experts in the field, including 3 independent advisory opinions. These letters were used to contextualize the objective record and explain how the client's research had contributed to subsequent developments in physical chemistry. One recommender observed:

 

“[Client’s] prowess in computer-aided drug design, biotechnology, atomic-level mechanism investigation, and rational material design situates her as a leader in the field and establishes [client’s] inherent value to the United States.”

 

Importantly, the letters supplemented rather than replaced the independent evidence of impact, including citations, comparative citation data, peer-review activity, competitive research funding, and documented use of the client's work by other researchers.

 

By connecting these different forms of evidence, we demonstrated not simply that the client had accumulated substantial scholarly credentials, but that other researchers had repeatedly recognized, evaluated, cited, and built upon the client's work. The record also showed that the client's scholarship had received competitive research funding, further contextualizing the value placed on the research. Taken as a whole, this evidence supported the final merits argument that the client's accomplishments reflected sustained recognition and a level of expertise consistent with the EB-1A classification. The client's I-140 EB-1A petition was ultimately approved, allowing the client to continue pursuing physical chemistry research with applications across computational drug discovery and other advanced technologies.